These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19709859)

  • 1. The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: a naturalistic study of the North American Prodrome Longitudinal Sample.
    Walker EF; Cornblatt BA; Addington J; Cadenhead KS; Cannon TD; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Woods SW; Heinssen R
    Schizophr Res; 2009 Nov; 115(1):50-7. PubMed ID: 19709859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents.
    Cornblatt BA; Lencz T; Smith CW; Olsen R; Auther AM; Nakayama E; Lesser ML; Tai JY; Shah MR; Foley CA; Kane JM; Correll CU
    J Clin Psychiatry; 2007 Apr; 68(4):546-57. PubMed ID: 17474810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment history in the psychosis prodrome: characteristics of the North American Prodrome Longitudinal Study Cohort.
    Cadenhead KS; Addington J; Cannon T; Cornblatt B; McGlashan T; Perkins D; Seidman L; Tsuang M; Walker E; Woods S; Heinssen R
    Early Interv Psychiatry; 2010 Aug; 4(3):220-6. PubMed ID: 20712727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms.
    Addington J; Liu L; Buchy L; Cadenhead KS; Cannon TD; Cornblatt BA; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; McGlashan TH
    J Nerv Ment Dis; 2015 May; 203(5):328-35. PubMed ID: 25919383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant, antipsychotic and psychological interventions in subjects at high clinical risk for psychosis: OASIS 6-year naturalistic study.
    Fusar-Poli P; Frascarelli M; Valmaggia L; Byrne M; Stahl D; Rocchetti M; Codjoe L; Weinberg L; Tognin S; Xenaki L; McGuire P
    Psychol Med; 2015 Apr; 45(6):1327-39. PubMed ID: 25335776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic interventions in prodromal psychosis: safety issues.
    Liu CC; Demjaha A
    CNS Drugs; 2013 Mar; 27(3):197-205. PubMed ID: 23436256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological treatment for psychotic depression.
    Wijkstra J; Lijmer J; Burger H; Geddes J; Nolen WA
    Cochrane Database Syst Rev; 2013 Nov; (11):CD004044. PubMed ID: 24282034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptomatic and functional remission of subjects at clinical high risk for psychosis: a 2-year naturalistic observational study.
    Lee TY; Kim SN; Correll CU; Byun MS; Kim E; Jang JH; Kang DH; Yun JY; Kwon JS
    Schizophr Res; 2014 Jul; 156(2-3):266-71. PubMed ID: 24815568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortisol levels and risk for psychosis: initial findings from the North American prodrome longitudinal study.
    Walker EF; Trotman HD; Pearce BD; Addington J; Cadenhead KS; Cornblatt BA; Heinssen R; Mathalon DH; Perkins DO; Seidman LJ; Tsuang MT; Cannon TD; McGlashan TH; Woods SW
    Biol Psychiatry; 2013 Sep; 74(6):410-7. PubMed ID: 23562006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive changes following antidepressant or antipsychotic treatment in adolescents at clinical risk for psychosis.
    Bowie CR; McLaughlin D; Carrión RE; Auther AM; Cornblatt BA
    Schizophr Res; 2012 May; 137(1-3):110-7. PubMed ID: 22377102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further evidence that antipsychotic medication does not prevent long-term psychosis in higher-risk individuals.
    Zhang T; Wang J; Xu L; Wei Y; Tang X; Hu Y; Cui H; Tang Y; Li C; Ling Z; Wang J
    Eur Arch Psychiatry Clin Neurosci; 2022 Jun; 272(4):591-602. PubMed ID: 34536114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From the psychosis prodrome to the first-episode of psychosis: No evidence of a cognitive decline.
    Carrión RE; Walder DJ; Auther AM; McLaughlin D; Zyla HO; Adelsheim S; Calkins R; Carter CS; McFarland B; Melton R; Niendam T; Ragland JD; Sale TG; Taylor SF; McFarlane WR; Cornblatt BA
    J Psychiatr Res; 2018 Jan; 96():231-238. PubMed ID: 29121595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale for clinical interventions in prodromal psychosis. Are such interventions safe?
    Agius M; Butler S
    Psychiatr Danub; 2012 Sep; 24 Suppl 1():S28-35. PubMed ID: 22945183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latent class cluster analysis of symptom ratings identifies distinct subgroups within the clinical high risk for psychosis syndrome.
    Ryan AT; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Woods SW; Cannon TD; Walker EF
    Schizophr Res; 2018 Jul; 197():522-530. PubMed ID: 29279247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External validation and extension of the NAPLS-2 and SIPS-RC personalized risk calculators in an independent clinical high-risk sample.
    Osborne KJ; Mittal VA
    Psychiatry Res; 2019 Sep; 279():9-14. PubMed ID: 31279247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adolescents and adults at clinical high-risk for psychosis: age-related differences in attenuated positive symptoms syndrome prevalence and entanglement with basic symptoms.
    Gerstenberg M; Theodoridou A; Traber-Walker N; Franscini M; Wotruba D; Metzler S; Müller M; Dvorsky D; Correll CU; Walitza S; Rössler W; Heekeren K
    Psychol Med; 2016 Apr; 46(5):1069-78. PubMed ID: 26671170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early intervention in patients at ultra high risk of psychosis: benefits and risks.
    de Koning MB; Bloemen OJ; van Amelsvoort TA; Becker HE; Nieman DH; van der Gaag M; Linszen DH
    Acta Psychiatr Scand; 2009 Jun; 119(6):426-42. PubMed ID: 19392813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.